PT1231211E - Derivados de tiazolidinadiona como agentes antidiabeticos - Google Patents

Derivados de tiazolidinadiona como agentes antidiabeticos

Info

Publication number
PT1231211E
PT1231211E PT00974559T PT00974559T PT1231211E PT 1231211 E PT1231211 E PT 1231211E PT 00974559 T PT00974559 T PT 00974559T PT 00974559 T PT00974559 T PT 00974559T PT 1231211 E PT1231211 E PT 1231211E
Authority
PT
Portugal
Prior art keywords
tiazolidinadiona
derivatives
antidiabetic agents
antidiabetic
agents
Prior art date
Application number
PT00974559T
Other languages
English (en)
Inventor
Marisabel Mourelle Mancini
Juan Carlos Del Castillo Nieto
Elisabet De Ramon Amat
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of PT1231211E publication Critical patent/PT1231211E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT00974559T 1999-11-18 2000-11-15 Derivados de tiazolidinadiona como agentes antidiabeticos PT1231211E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
PT1231211E true PT1231211E (pt) 2003-09-30

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00974559T PT1231211E (pt) 1999-11-18 2000-11-15 Derivados de tiazolidinadiona como agentes antidiabeticos

Country Status (37)

Country Link
US (1) US7001910B1 (pt)
EP (1) EP1231211B1 (pt)
JP (1) JP2003514817A (pt)
KR (1) KR100518110B1 (pt)
CN (1) CN1159314C (pt)
AP (1) AP1330A (pt)
AR (1) AR031080A1 (pt)
AT (1) ATE241622T1 (pt)
AU (1) AU770045B2 (pt)
BG (1) BG106699A (pt)
BR (1) BR0015613A (pt)
CA (1) CA2391913A1 (pt)
CO (1) CO5261560A1 (pt)
CR (1) CR6640A (pt)
CZ (1) CZ20021654A3 (pt)
DE (1) DE60003072T2 (pt)
DK (1) DK1231211T3 (pt)
EA (1) EA004301B1 (pt)
EE (1) EE200200254A (pt)
ES (2) ES2156574B1 (pt)
GE (1) GEP20043240B (pt)
HR (1) HRP20020426A2 (pt)
HU (1) HUP0203478A2 (pt)
IL (1) IL149634A0 (pt)
IS (1) IS2014B (pt)
MA (1) MA26844A1 (pt)
MX (1) MXPA02005011A (pt)
NO (2) NO20022336L (pt)
NZ (1) NZ519264A (pt)
OA (1) OA12089A (pt)
PE (1) PE20010858A1 (pt)
PL (1) PL354877A1 (pt)
PT (1) PT1231211E (pt)
SK (1) SK6752002A3 (pt)
WO (1) WO2001036416A1 (pt)
YU (1) YU40202A (pt)
ZA (1) ZA200203906B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
CN1402724A (zh) 2003-03-12
KR20020079737A (ko) 2002-10-19
WO2001036416A1 (es) 2001-05-25
EP1231211B1 (en) 2003-05-28
HUP0203478A2 (hu) 2003-02-28
NO20022336D0 (no) 2002-05-15
MXPA02005011A (es) 2003-10-14
AR031080A1 (es) 2003-09-10
PE20010858A1 (es) 2001-08-22
PL354877A1 (en) 2004-03-08
CA2391913A1 (en) 2001-05-25
ES2156574A1 (es) 2001-06-16
NO20022379D0 (no) 2002-05-16
HRP20020426A2 (en) 2004-02-29
ATE241622T1 (de) 2003-06-15
IS2014B (is) 2005-06-15
US7001910B1 (en) 2006-02-21
BG106699A (bg) 2003-02-28
DE60003072T2 (de) 2004-04-01
AU770045B2 (en) 2004-02-12
JP2003514817A (ja) 2003-04-22
MA26844A1 (fr) 2004-12-20
NO20022336L (no) 2002-07-09
SK6752002A3 (en) 2002-09-10
IS6386A (is) 2002-05-15
DK1231211T3 (da) 2003-10-27
GEP20043240B (en) 2004-05-25
OA12089A (en) 2006-05-04
IL149634A0 (en) 2002-11-10
YU40202A (sh) 2006-01-16
NZ519264A (en) 2003-10-31
BR0015613A (pt) 2002-07-23
ES2199878T3 (es) 2004-03-01
KR100518110B1 (ko) 2005-10-04
CO5261560A1 (es) 2003-03-31
EP1231211A1 (en) 2002-08-14
ZA200203906B (en) 2004-03-26
DE60003072D1 (de) 2003-07-03
CN1159314C (zh) 2004-07-28
EE200200254A (et) 2003-06-16
ES2156574B1 (es) 2002-02-01
AU1281501A (en) 2001-05-30
AP1330A (en) 2004-11-25
AP2002002512A0 (en) 2002-06-30
CR6640A (es) 2004-03-05
CZ20021654A3 (cs) 2002-09-11
EA004301B1 (ru) 2004-02-26
EA200200470A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
PT1084114E (pt) Derivados isotiazole uteis como agentes anticancerigenos
PT1177185E (pt) Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais
PT1287001E (pt) Derivados de tiofeno uteis como agentes anticancerigenos
PT1028961E (pt) Derivados de pleuromutilina como agentes antimicrobianos
EE200200273A (et) Uudsed diabeedivastased agensid
IS2116B (is) 4-fenyl-pyridin afleiður
DE60009747D1 (de) Admantan-derivate
DE50010060D1 (de) Thiazolylamid-derivate
PT1280795E (pt) Derivados de carbamoiloalquil-azolio n-substituidos
EE200100613A (et) 13-metüülerütromütsiini derivaadid
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE257148T1 (de) Propargyletherderivate
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
PT1231211E (pt) Derivados de tiazolidinadiona como agentes antidiabeticos
PT1187815E (pt) Derivados de 4-fenil-pirimidina
DE60006703D1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de) Resorcinderivate
PT1075471E (pt) Derivados de indolilo como agentes seronergicos
PT1088818E (pt) Derivados de quinolin-4-ilo
PT1194401E (pt) Derivados de diacil-hidrazina
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
PT1015446E (pt) Derivados de (4-piperidinil)-1h-2-benzopirano uteis como agentes antipsicoticos
PT1330453E (pt) Derivados de indolilpiperidina como agentes anti-histaminicos e antialergicos
DK1189886T3 (da) Ethansulfonyl-piperidinderivater